Efficacy and safety of a modified- ‘modified Ponticelli’ regimen for treatment of primary membranous nephropathy
Background: Modified Ponticelli regimen (mPR), consisting of cyclical steroids and cyclophosphamide, is the most established therapy for primary membranous nephropathy (MN). Yet, the potential toxicity of this treatment regimen poses a significant concern. Objectives: The aim of this study was to as...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Diabetic Nephropathy Prevention
2019-07-01
|
Series: | Journal of Nephropathology |
Subjects: | |
Online Access: | https://nephropathol.com/PDF/jnp-8-e25.pdf |